Mayo Clinic, Transplant Genomics Ink Collaboration | GenomeWeb

NEW YORK (GenomeWeb) – Transplant Genomics has announced a collaboration with the Mayo Clinic to develop, validate, and commercialize diagnostic testing for solid organ transplant recipients.

Under the terms of the agreement the partners will perform a multi-year assessment of the firm's TruGraf test for renal transplant monitoring at Mayo campuses in Minnesota, Arizona, and Florida. They will also co-develop new tests for other types of organ and will launch exploratory studies of heart and liver transplantation monitoring.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.